iShares Genomics Immunology and Healthcare ETF (IDNA)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreTop 10 Holdings (48.44% of Total Assets)
Sector Weightings
Overall Portfolio Composition (%)
| Stocks | 99.67% |
| Bonds | 0.00% |
|---|
Equity Holdings
| Price/Earnings | 0 |
| Price/Book | 0.27 |
|---|---|
| Price/Sales | 0.19 |
| Price/Cashflow | 0 |
| Median Market Cap | -- |
| 3 Year Earnings Growth | -- |
Bond Ratings
| US Government | 0.00% |
| AAA | -- |
|---|---|
| AA | -- |
| A | -- |
| BBB | -- |
| BB | -- |
| B | -- |
| Below B | -- |
| Other | -- |
ETF Summary
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
ETF Overview
| Category | Health |
|---|---|
| Fund Family | iShares |
| Net Assets | 298.98M |
| YTD Daily Total Return | 64.83% |
| Yield | 0.66% |
| Legal Type | Exchange Traded Fund |
